Taurine

Studies of taurine in people

86 studies gave taurine to people and measured what changed

What changedDesignPeopleSource

no change: Has no effect on fatigue severitymean difference -1.25 (95% CI -3.55 to 1.05); p=0.288

down: Decreases fatigue severity-11.90±4.04 vs -4.57±9.23; Cohen's d -1.02

Randomized trial12 weeks220 peopleUnselected patients with decompensated cirrhosisHepatology communications, Apr 24, 2026

down: Decreases aspartate aminotransferase

down: Lowers the risk of mortalityp < 0.05

down: Decreases hospital staymean difference -3.49 days

Randomized trial30 days169 peopleadultsClinical nutrition ESPEN, Jan 26, 2026

up: Increases blood lactateT group peak values higher than P group (P = 0.04)

up: Increases tympanic temperatureT group peak values higher than P group (P < 0.01)

Randomized trial12 peopleDuring exhaustive exercise under hot and humid conditionsSports health, Feb 19, 2025

up: Improves countermovement jump height43.42 ± 3.46 vs 38.58 ± 3.86

Randomized trial16 people16 male university football players23.69 ± 2.15 yearsMale university football playersScientific reports, Feb 13, 2025

down: Decreases triglycerideWMD -0.56 mg/dL, 95% CI -0.92 to -0.2

down: Decreases fasting insulinWMD -2.15 μU/mL, 95% CI -3.24 to -1.06

down: Decreases HOMA-IRWMD -0.91, 95% CI -1.74 to -0.08

Review of trialslong-termadultsIn obese participants (subgroup analysis)Nutrients, Dec 27, 2024

no change: Has no effect on maximal fat oxidationd = -0.07; 0.48 vs 0.49 g/min

no change: Has no effect on time to exhaustiond = -0.04; 1,444.8 vs 1,447.6 s

no change: Has no effect on VO2peakd = 0.48; 58.9 vs 56.5 ml·kg-1·min-1

Randomized trial11 peopleMenSingle 6 g dose 90 min before incremental running test, versus placeboInternational journal of sport nutrition and exercise metabolism, Nov 19, 2024

up: Increases breakpoint of compensabilityCohen's d = 0.97

up: Increases whole-body sweat loss

up: Increases evaporative heat lossCohen's d = 0.79

Randomized trial8-days15 peopleBoth27 ± 5 yearsEuropean journal of applied physiology, Apr 6, 2024

no change: Has no effect on mortalityRR 0.70, 95% CI 0.28 to 1.80

no change: Has no effect on ICU length of stay

down: Decreases IL-6

Review of trials176 people pooledPatient cohortsClinical nutrition ESPEN, Mar 28, 2024

up: Improves time to exhaustion

down: Decreases blood lactated = 0.8 versus CAF; d = 0.7 versus TAU + CAF

Randomized trial12 peopleCycling in heat (35°C, 65% relative humidity)Sports health, Feb 26, 2024

up: Improves peak power

no change: Has no effect on peak power

no change: Has no effect on blood lactate

Randomized trialsingle dose 1 h before test16 peopleWomen21.3 ± 1.5 yrResearch in sports medicine (Print), Apr 6, 2023

up: Improves anaerobic power output

Randomized trialfour times in a 72 h window20 peoplemale22.14 ± 1.42 yearsElite male boxer athletesNutrients, Oct 20, 2022

down: Decreases delirium9.46% vs 35.36% placebo, P = 0.012

Randomized trial30 days207 peopleolder than 18 yearsAfter liver transplantation, delirium assessed by CAM-ICUClinical nutrition (Edinburgh, Scotland), Aug 7, 2022

up: Increases superoxide dismutase

no change: Has no effect on glutathione reductase

up: Increases plasma taurine concentration

Randomized trial16 wk24 peopleWomen55 to 70 yearsMidlife adults; Older adultsNutrition (Burbank, Los Angeles County, Calif.), Apr 22, 2022

up: Increases anti-inflammatory interleukins

down: Decreases adipocyte size

no change: Has no effect on anthropometric characteristics

Randomized trial8 weeks16 peopleWomenPatient cohortsAmino acids, Jul 13, 2021

down: Decreases IL-6− 70.75 ± 71.89 vs. -20.09 ± 59.51

up: Improves glasgow Coma Scale

down: Decreases weight loss

Randomized trial14 days44 peopleover the age of 18 yearsTBI patients, who were admitted to the ICUNutrition journal, Jun 8, 2021

down: Decreases muscle cramps

no change: Has no effect on taurine

Trial4 weeks10 people6 patients (60%) were malesmedian 66 years (IQR 58–75)Patients with liver cirrhosis experiencing muscle cramps one or more times per weekYonsei medical journal, Jan 1, 2021

down: Decreases LDL cholesterolp = 0.03 vs control group

down: Decreases leptinp = 0. 006 vs control group

down: Decreases C-reactive proteinp = 0.03 vs control group

Randomized trial8 weeks20 peopleWomenPatient cohortsAmino acids, Jul 21, 2020

down: Decreases fasting blood sugar

down: Decreases LDL cholesterol

no change: Has no effect on HbA1c

Randomized trial8 weeks45 peopleTaurine group versus placebo after 8 weeksAmino acids, May 29, 2020

no change: Has no effect on glycerol

Randomized trialone hour17 peoplemale24.8 ± 4.07 yActive male, healthy subjectsNutrients, May 25, 2020

down: Decreases glycated hemoglobin

down: Decreases low-density lipoprotein cholesterol

down: Decreases pentosidine

Randomized trial8 weeks46 peopleTaurine compared with placebo at completionCanadian journal of diabetes, May 17, 2020

up: Increases irisinp < 0.001 at 1 h after exercise, taurine group only

Randomized trial8 weeks8 peopleWomen36.6 ± 6.4 yearsTaurine group, 1 h after exerciseCytokine, Jun 18, 2019

no change: Has no effect on oxidative stress and inflammatory parameters

up: Improves flow-mediated dilation

Trial4 days14 peopleBoth8-35 yearsIn individuals with pretreatment FMD below 10%Journal of inherited metabolic disease, Apr 11, 2019

up: Increases time to exhaustion+10% (25.16 min vs. 22.43 min)

up: Increases end-exercise sweat rate+12.7% (687 nL min−1 vs. 600 nL min−1)

down: Decreases blood lactate−16.5% (5.75 mmol L−1 vs. 6.85 mmol L−1)

Randomized trial11 peopleMenCycling at ventilatory threshold power output in the heat (35°C, 40% RH)European journal of sport science, Feb 18, 2019

up: Increases flow-mediated dilation

no change: Has no effect on resistance exercise-induced reduction in flow-mediated dilation

Randomized trial2 weeks29 peopleMenAt rest, before exerciseAdvances in experimental medicine and biology, Jan 1, 2019

up: Improves MMSE-DS total score14.2 to 16.7 points

Trial4 weeks16 peopleWomenelderlyOlder adults; taurine supplement group (TG) served with SATL menuAdvances in experimental medicine and biology, Jan 1, 2019

up: Increases serum taurine218.0 ± 15.6 μM at 4 weeks, significantly higher than control

up: Improves language and executive performance

Randomized trial4 weeks31 peopleWomenelderlyOlder adults; Patient cohortsAdvances in experimental medicine and biology, Jan 1, 2019

down: Decreases muscle cramp frequencyseven cramps fewer per fortnight vs placebo

up: Increases serum taurine

no change: Has no effect on adverse side effects

Randomized trial4 weeks per arm30 peopleBothmean 54.7 years2 g/d versus placebo in a randomized crossover designAlimentary pharmacology & therapeutics, Aug 23, 2018

down: Decreases stroke-like episodes

up: Increases tRNALeu(UUR) taurine modification rate

Trial52 weeks10 peoplemean 29.1 years (range 14–46)Patients diagnosed with MELASJournal of neurology, neurosurgery, and psychiatry, Apr 17, 2018

down: Decreases heart rated = 2.1

up: Improves end-test powerd = 3.7

down: Impairs peak sprint power

Randomized trial9 peopleWomenBefore the ramp test, versus placeboAmino acids, Mar 17, 2018

down: Decreases IL-1β/IL-1ra ratio

up: Increases neuron-specific enolase

Randomized trial14 weeks48 peopleWomen83.58 ± 6.9 yearsOlder adultsApplied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, Feb 23, 2018

down: Decreases isokinetic peak torque-16.1% first; -5.0% best

down: Decreases isokinetic power output-17.7% first; -8.0% best

up: Improves maximal voluntary muscle power5.2% best power

Randomized trial14 peopleMen21.8 ± 2.5 yrIn noncaffeine consumersMedicine and science in sports and exercise, Feb 1, 2018

up: Improves repeated sprint performance

up: Improves mean peak powersmall, possible

up: Increases intrasprint fatigue indexmoderate, likely

Randomized trial7 peopleMenRepeated Wingate cyclingInternational journal of sports physiology and performance, Dec 28, 2017

down: Decreases hepatic venous pressure gradient-12% relative change in HVPG with taurine (20 to 18 mm Hg); between-group P = .0091 absolute, P = .0109 relative

no change: Has no effect on systemic haemodynamics

Randomized trial4 weeks22 peopleBothmean 52 ± 11 yearsPatient cohortsAlimentary pharmacology & therapeutics, Nov 3, 2017

up: Increases creatine kinase

no change: Has no effect on lactate dehydrogenase

no change: Has no effect on inflammatory markers IL-6 and TNF-α

Randomized trial8 weeks9 peopleMen25-35 yearsAfter TAU supplementationThe Journal of sports medicine and physical fitness, Jul 25, 2017

down: Decreases C-reactive protein

down: Decreases Castelli risk index I

up: Increases taurine

Randomized trial2 weeksBefore and after incremental exercise in heart failure patientsTherapeutic advances in cardiovascular disease, Jun 5, 2017

up: Improves global functioning95% CI 0.3 to 8.8; P = .04

no change: Has no effect on cognitive function95% CI -1.7 to 1.0; P = .582

down: Decreases asthenia, lassitude and fatigabilityP = .006

Randomized trial12 weeks86 people18-25 yearsAdjunctive to low-dose antipsychotic medicationThe Journal of clinical psychiatry, Dec 1, 2016

up: Increases endothelial progenitor cell colony formation

Randomized trial2 weeks125 peopleAll of the participants were men18–25 yearsHealthy menHypertension research : official journal of the Japanese Society of Hypertension, Jul 14, 2016

no change: Has no effect on physical function

no change: Has no effect on lactate

Randomized trialsingle acute dose11 peoplemalemean ± SD age 34.6 ± 11.5 yearsMale trained cyclistsAmino acids, Jul 5, 2016

down: Decreases delayed increase in carotid-femoral pulse wave velocity after eccentric exercise

down: Decreases exercise-induced increase in serum malondialdehyde

Randomized trial14 days before exercise through 3 days after29 peopleMenyoungAfter eccentric exercise, taurine vs placeboApplied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, Feb 9, 2016

down: Decreases blood pressureclinic systolic BP reduction 7.2 mm Hg (taurine) vs 2.6 mm Hg (placebo)

up: Improves endothelium-dependent and endothelium-independent vasodilation

up: Increases plasma hydrogen sulfide

Randomized trial12 weeks120 peopleIn prehypertensive individualsHypertension (Dallas, Tex. : 1979), Jan 18, 2016